sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > Others > Signaling pathway-Others > LY2109761
LY2109761  
Catalog No. T2123    CAS 700874-71-1
Pack Size
Availability
Price/USD
Quantity
1mg
In stock
50.00
5mg
In stock
80.00
10mg
In stock
144.00
25mg
In stock
259.00
50mg
In stock
432.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:98.00% COA Datasheet HNMR HPLC MSDS
Biological Activity:

Product Description:

LY2157299 is a selective inhibitor of the TGF-β receptor I/II kinases (Ki: 38/300 nM).

Target:
TβRII; TβRI; TGF-β receptor typeII; TGF-β receptor type I;
Research Area:
Chemical Information:
Molecular Weight 441.52
Formula C26H27N5O2
CAS Number 700874-71-1
Solubility DMSO:20 mg/mL;Ethanol: Insoluble; Water; Insoluble
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
Product Recommendations
  • KHS 101, KHS101 is a novel inhibitor of transforming acidic coiled-coil protein 3 (TACC3). It is a selective...
  • MKT-077, MKT-077 is a cationic rhodacyanine dye that demonstrates antiproliferative activity against cancer c...
  • Corynoxine hydrochloride(6877-32-3(free base)),

    Corynoxine is a natural oxindole alkaloid and induces autophagy in different neuronal cell lines,...

  • Eptifibatide acetate, Eptifibatide, an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class, is a cyclic heptape...
  • Atosiban acetate, Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medi...

 

Reference

If you have additional questions, Please send us a message. * Required